CAH - Cardinal Health, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $273.22 DETAILS

Stock News

CAH Gains More Than 29% in 4 Months: Will the Uptrend Continue?

Cardinal Health's 29% rally reflects stronger specialty growth, MSO expansion and higher-margin assets, but cost pressures could test the uptrend.

Sep 11, 2026 11:26 AM • zacks.com

Cardinal (CAH) Up 2.5% Since Last Earnings Report: Can It Continue?

Cardinal (CAH) reported earnings 30 days ago. What's next for the stock?

Sep 10, 2026 08:31 AM • zacks.com

Cardinal Health, Inc. (CAH) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Sep 09, 2026 06:57 AM • seekingalpha.com

Cardinal Health (CAH) Declines More Than Market: Some Information for Investors

In the latest trading session, Cardinal Health (CAH) closed at $240.49, marking a -2.71% move from the previous day.

Sep 08, 2026 03:00 PM • zacks.com

Is Cardinal Health Building a New Tech-Enabled Healthcare Platform?

Technology is becoming a bigger part of CAH's strategy, linking distribution, specialty services and logistics through digital workflows.

Sep 08, 2026 08:11 AM • zacks.com

Here's Why Cardinal Health (CAH) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Sep 08, 2026 06:41 AM • zacks.com

Cardinal Health (CAH) is a Top-Ranked Growth Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Sep 03, 2026 06:46 AM • zacks.com

Is Generics Still a Quiet Profit Engine for Cardinal Health?

Cardinal Health's generic volumes, profitable brand-to-generic conversions and Red Oak program continue to support Pharma profits.

Sep 03, 2026 05:26 AM • zacks.com

Neurocrine's Crenessity Gains Ground in CAH: How Far Can Sales Go?

NBIX's Crenessity gains rapid traction in CAH, with sales soaring and low patient penetration leaving room for growth.

Aug 31, 2026 09:36 AM • zacks.com

3,554 Shares in Cardinal Health, Inc. $CAH Bought by Connor Clark & Lunn Investment Management Ltd.

Connor Clark and Lunn Investment Management Ltd. bought a new position in shares of Cardinal Health, Inc. (NYSE: CAH) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 3,554 shares of the company's stock, valued at approximately $844,000. Other large investors also

Aug 31, 2026 12:31 AM • defenseworld.net

Cardinal Health (CAH) is a Top-Ranked Momentum Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Aug 28, 2026 06:51 AM • zacks.com

Cardinal Health, Inc. $CAH Shares Bought by Algert Global LLC

Algert Global LLC grew its holdings in shares of Cardinal Health, Inc. (NYSE: CAH) by 246.9% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 36,993 shares of the company's stock after purchasing an additional 26,330 shares during the quarter.

Aug 27, 2026 12:41 AM • defenseworld.net

Reasons to Retain Cardinal Health Stock in Your Portfolio for Now

CAH enters fiscal 2027 with strong specialty growth, but IRA pricing changes, GMPD challenges and heavy CapEx pose risks.

Aug 24, 2026 11:51 AM • zacks.com

What to Know About the Latest Sale From Cardinal Health's Chief Accounting Officer

The sale involved 2,302 shares at $237.39 per share, resulting in a transaction value of $546,500. All shares were held directly; no indirect ownership through entities or trusts was disclosed in the filing.

Aug 23, 2026 03:38 AM • fool.com

Cardinal Health's CFO Moved $9.9 Million of Stock. Here's What Long-Term Investors Should Know

The transaction involved 42,000 shares with a total value of ~$9.9 million on August 18. Following the sale, the executive retains 20,495 shares held directly, with no reported indirect ownership.

Aug 23, 2026 03:31 AM • fool.com

Cardinal Health's Medical Segment Boss Sold $8 Million in Stock. Here's What to Know

The disposition of 35,000 shares on August 18 generated a total transaction value of $8.3 million. The transaction involved exclusively directly held shares, with the insider reporting no indirect ownership in this filing.

Aug 23, 2026 03:22 AM • fool.com

Cardinal Health's Pharma Chief Sold 7,354 Shares and Still Grew Her Stake by 47%. Here's How That Happened

Deborah Weitzman sold 7,354 shares for approximately $1.7 million on August 18. The entire disposition was executed through direct ownership, with no indirect holdings reported in the filing.

Aug 23, 2026 03:14 AM • fool.com

The CIO of Cardinal Health Parted With 11,650 Shares. Here's Whether It Matters for Long-Term Investors

The disposition involved 11,650 shares at a weighted average price of $235.72, totaling approximately $2.7 million. Greene executed the sale directly and maintains no indirect equity holdings through trusts or other legal entities.

Aug 23, 2026 03:07 AM • fool.com

Cardinal Health's Legal Chief Just Filed an Insider Transaction. Here's What to Know

The sale realized $7.0 million based on a weighted average execution price. The transaction represents a 47% reduction in Mayer direct equity holdings.

Aug 23, 2026 02:54 AM • fool.com

Cardinal Health's CEO Moved 124,529 Shares in Two Days. Here's What Long-Term Investors Should Know

Jason M. Hollar disposed of 125,000 shares at a weighted average price of $235.89 per share across two trading sessions. The divestment involved only directly held shares; Hollar retains nearly 191,000 shares valued at $44.76 million following the sale.

Aug 23, 2026 02:24 AM • fool.com